← Alle mensen

DH

Dingzhi Huang

9 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Tislelizumab plus chemotherapie versus placebo plus chemotherapie bij extensive-stage SCLC: langetermijnresultaten

Journal of Thoracic Oncology · 5 maart 2026

Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Fase III IPSOS Study.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-12

Fase II Dose-Gerandomiseerde Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal ...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 oktober 2025

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blin...

Lancet (London, England) · 8 maart 2025

Tislelizumab plus platina-etoposide bij eerstelijns SCLC: RATIONALE 312 fase III

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024-07

Eerstelijns atezolizumab mono versus chemotherapie bij NSCLC: IMpower110 langetermijn

Lancet (London, England) · 5 augustus 2023

Tislelizumab versus docetaxel bij eerder behandeld NSCLC: RATIONALE-303 fase III

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023-01

Sintilimab plus platina-gemcitabine als eerstelijns bij plaveiselcel NSCLC: ORIENT-12 fase III

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021-09

Camrelizumab plus apatinib bij uitgebreid SCLC: PASSION fase II

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021-02